SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

Share Price is delayed by 15 minutes
Get Live Data
392.00    2.00 (0.51%)
Bid:
385.00
Ask:
399.00
Spread: 14.00 (3.636%)
Market Cap: £188.15m
TSTL Live PriceLast checked at - London Stock Exchange

Intraday Tristel Share Chart

Director/PDMR Shareholding (Replacement)

25 Feb 2020 09:06

RNS Number : 0359E
Tristel PLC
25 February 2020
 

The following amendments have been made to the (Director/PDMR Shareholding) announcement released on 25 February 2020 at 0700hrs under RNS No 9708D

Paul Barnes' resultant shareholding in the Company is 351,095 Ordinary Shares representing 0.78%

All other details remain unchanged.

The full amended text is shown below.

Tristel plc

("Tristel" or the "Company")

Director/PDMR Shareholding

Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, has been notified by Paul Barnes, Non-Executive Director, that he has sold 15,000 ordinary shares of 1 penny each in the Company ("Ordinary Shares") at a price of 422.25 pence per Ordinary Share on 24 February 2020. Paul Barnes' resultant shareholding in the Company is 351,095 Ordinary Shares representing 0.78% of the issued share capital of the Company.

For further information please contact:

 

Tristel plc

Tel: 01638 721 500

Paul Swinney, Chief Executive Officer

 

Liz Dixon, Finance Director

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or tristel@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07854 391 303

 

 

finnCap

Tel: 020 7220 0500

Geoff Nash (Corporate Finance)

 

Giles Rolls (Corporate Finance)

 

Alice Lane (ECM)

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Paul Barnes

2.

Reason for the Notification. Sale of Ordinary Shares

a)

Position/status

Director

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tristel plc

b)

LEI

2138009DZ4LH9CZGF662

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Ordinary shares of 1p

Identification code

GB00B07RVT99

b)

Nature of the transaction

 

Sale of Ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

4.2225 GBP

15,000

d)

Aggregated information:

·; Aggregated volume

·; Price

 

Sale of 15,000 ordinary shares of 1p at £4.2225 per ordinary share

e)

Date of the transaction

24/02/2020

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUVRKRRSUUURR
Date   Source Headline
11th Dec 201212:56 pmRNSResult of AGM
29th Oct 20127:00 amRNSFinal Results
29th Aug 20127:00 amRNSDirector/PDMR Shareholding
8th Aug 20127:00 amRNSDirectorate Change
2nd Aug 20127:00 amRNSNew website
23rd Jul 201210:29 amRNSDirector/PDMR Shareholding
23rd Jul 20127:00 amRNSTrading update
9th Jul 20127:00 amRNSSupply&distribution agreement - Basan Germany GmbH
25th Jun 20127:00 amRNSDirectorate Change
15th Jun 201211:40 amRNSDirectors' Shareholdings
15th Jun 20127:00 amRNSTrading Update
12th Jun 20127:00 amRNSResult of Clinical Study
30th Apr 20129:00 amRNSDirectors' Dealings
3rd Apr 20127:00 amRNSTermination of supply arrangement
30th Mar 20127:00 amRNSResults of Clinical Study
12th Mar 20127:00 amRNSHalf Yearly Report
8th Mar 20127:00 amRNSNotice of Results
11th Jan 20123:17 pmRNSDirector/PDMR Shareholding
4th Jan 20128:50 amRNSDirector/PDMR Shareholding
23rd Dec 201112:16 pmRNSDirector/PDMR Shareholding
21st Dec 20113:40 pmRNSGrant of Share Options
13th Dec 201111:52 amRNSResult of AGM
8th Dec 20114:24 pmRNSDirector/PDMR Shareholding
25th Nov 20111:22 pmRNSDirector/PDMR Shareholding
22nd Nov 20117:00 amRNSDirector's Dealing
11th Nov 201110:27 amRNSDirector/PDMR Shareholding
4th Nov 20112:10 pmRNSDirector/PDMR Shareholding
24th Oct 20119:51 amRNSDirector/PDMR Shareholding
24th Oct 20117:01 amRNSDirectorate Change
24th Oct 20117:00 amRNSFinal Results
7th Sep 20117:00 amRNSFull regulatory approval for Fuse and Jet in China
9th Aug 20118:37 amRNSDirector's Shareholding
8th Aug 20117:00 amRNSCash inflow regarding R&D spend
25th Jul 20117:00 amRNSTrading update & notice of results
6th Jun 20117:00 amRNSApproval for Wipes System from VAH in Germany
12th May 20118:00 amRNSChina Licence received
6th May 20117:00 amRNSDirector Dealing
4th May 20112:38 pmRNSDirector Dealing
4th May 20117:00 amRNSDirector/PDMR Shareholding
28th Apr 20112:08 pmRNSTrading Update
14th Mar 20117:00 amRNSHalf Yearly Report
31st Jan 20117:00 amRNSCompletion of Clean Room & Notice of Results
30th Dec 20107:00 amRNSTermination of Agreement with Clorox
14th Dec 201011:15 amRNSResult of AGM
22nd Nov 201010:12 amRNSResult of General Meeting
12th Nov 201010:55 amRNSDirector/PDMR Shareholding
8th Nov 20103:06 pmRNSDirector Shareholding
5th Nov 201011:32 amRNSPlacing to raise £3.9million
18th Oct 20107:00 amRNSFinal Results
9th Sep 20107:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.